Why the study?
Diagnostic imaging may offer valuable complementary information to biochemical markers for diagnosis, organ monitoring, follow-up, and therapeutic development in metabolic disorders.
Diagnostic imaging can complement biochemical markers in the diagnosis and monitoring of metabolic disorders such as obesity and diabetes.
Answers are grounded in this paper and cite their sources.
May support multimodal monitoring in metabolic disorders; leaves open prospective validation before practice change.
Metabolic syndrome, obesity and diabetes mellitus are the most common metabolic disorders (MDs) in the world, characterized by abnormalities in body's metabolic processes. The typical diagnosis of MDs is usually executed by monitoring the levels of specific biochemical markers, but diagnostic imaging may provide valuable complementary information in MDs, offering advantages in diagnosis, target organ monitoring, follow-up, and development of new therapeutic approaches. The aim of this review is to summarize and discuss the studies published in the literature about the connection between images deriving from the diagnostic techniques and the key biochemical markers in the main MDs, in order to gain a comprehensive view of the different disorders.
No takes yet. Share an insight, caveat, or question.
Cianciosi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: